doi: 10.1016/s0960-894x(99)00376-5.
Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
Affiliations
- PMID: 10465562
- DOI: 10.1016/s0960-894x(99)00376-5
Item in Clipboard
Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
Bioorg Med Chem Lett.
.
Free article
Abstract
Epoxomicin (1), a peptide alpha',beta'-epoxyketone isolated from the actinomycete strain No.Q996-17, possesses potent in vivo anti-tumor and anti-inflammatory activities. In this paper, we report the first syntheses of epoxomicin, [3H]-epoxomicin, and a biotinylated epoxomicin analog as well as the absolute configuration of the epoxide stereocenter. The natural product and derivatives have permitted the first identification of the proteasome as the specific cellular target of epoxomicin.
Similar articles
-
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10403-8. doi: 10.1073/pnas.96.18.10403. Proc Natl Acad Sci U S A. 1999. PMID: 10468620 Free PMC article.
-
Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency.Bioorg Med Chem Lett. 1999 Dec 6;9(23):3335-40. doi: 10.1016/s0960-894x(99)00612-5. Bioorg Med Chem Lett. 1999. PMID: 10612595
-
Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.Chem Biol. 1999 Nov;6(11):811-22. doi: 10.1016/s1074-5521(99)80128-8. Chem Biol. 1999. PMID: 10574782
-
Lactacystin, proteasome function, and cell fate.J Biol Chem. 1998 Apr 10;273(15):8545-8. doi: 10.1074/jbc.273.15.8545. J Biol Chem. 1998. PMID: 9535824 Review. No abstract available.
-
Proteasomes and proteasome inhibition in the central nervous system.Free Radic Biol Med. 2001 Sep 1;31(5):574-84. doi: 10.1016/s0891-5849(01)00635-9. Free Radic Biol Med. 2001. PMID: 11522442 Review.
Cited by
-
The carmaphycins: new proteasome inhibitors exhibiting an α,β-epoxyketone warhead from a marine cyanobacterium.Chembiochem. 2012 Apr 16;13(6):810-7. doi: 10.1002/cbic.201200007. Epub 2012 Mar 1. Chembiochem. 2012. PMID: 22383253 Free PMC article.
-
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19. Pharmacol Ther. 2020. PMID: 32442437 Free PMC article.
-
Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion.EMBO J. 2001 Aug 1;20(15):4013-23. doi: 10.1093/emboj/20.15.4013. EMBO J. 2001. PMID: 11483505 Free PMC article.
-
Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice.Cell Mol Neurobiol. 2009 Jul;29(5):769-77. doi: 10.1007/s10571-009-9402-6. Epub 2009 Apr 16. Cell Mol Neurobiol. 2009. PMID: 19370411 Free PMC article.
-
Characterization of a novel mammalian phosphatase having sequence similarity to Schizosaccharomyces pombe PHO2 and Saccharomyces cerevisiae PHO13.Biochemistry. 2002 Jun 18;41(24):7841-8. doi: 10.1021/bi0255064. Biochemistry. 2002. PMID: 12056916 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
